Publications by authors named "A Osterborg"

Claim this Profile
T
T-cell immunomodulation occurs with different time kinetics during acalabrutinib and zanubrutinib therapy in chronic lymphocytic leukaemia.
Maria L Andersson, Olina Lind, Kia Heimersson, Anna Berglöf, Teresa Del Peso Santos

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of functional CD19 CAR T cells under hypoxic manufacturing conditions.
Isabella Micallef Nilsson, Thomas Poiret, Jinhye Ryu, Mohammadali Mohammadpour, Johan Henriksson

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies.
Constantine S Tam, Mary Ann Anderson, Martin Simkovic, Paolo Ghia, Ian W Flinn

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era.
Pontus Hedberg, Lisa Blixt, Sandra Eketorp Sylvan, Isabela Killander Möller, Hannes Lindahl

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Tumor Microenvironment Interactions in Chronic Lymphocytic Leukemia Using Leukotriene Inhibitors.
Laia Sadeghi, Magali Merrien, Magnus Björkholm, Anders Österborg, Birgitta Sander

Int J Mol Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis